Patents by Inventor Ishir Bhan

Ishir Bhan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230407312
    Abstract: The invention relates methods of using RNAi agents to inhibit expression of HAO1 and methods of treating subjects having primary hyperoxaluria, e.g., PH1.
    Type: Application
    Filed: May 26, 2023
    Publication date: December 21, 2023
    Inventors: Tracy L. McGregor, John Michael Gansner, Ishir Bhan
  • Patent number: 9671414
    Abstract: Described herein are assays directed to determining the level of bioavailable or free vitamin D in a blood sample in a subject. The values determined for bioavailable or free vitamin D indicate whether the subject suffers from insufficient levels of vitamin D. Also described herein are methods of treatment for vitamin D insufficiency.
    Type: Grant
    Filed: May 2, 2014
    Date of Patent: June 6, 2017
    Assignees: Beth Israel Deaconess Medical Center, Inc., The General Hospital Corporation
    Inventors: Ravi Thadhani, S. Ananth Karumanchi, Anders Hayden Berg, Ishir Bhan
  • Patent number: 9606131
    Abstract: Described herein are assays directed to determining the level of bioavailable or free vitamin D in a blood sample in a subject. The values determined for bioavailable or free vitamin D indicate whether the subject suffers from insufficient levels of vitamin D. Also described herein are methods of treatment for vitamin D insufficiency.
    Type: Grant
    Filed: May 11, 2015
    Date of Patent: March 28, 2017
    Assignees: The General Hospital Corporation, Beth Israel Deaconess Medical Center, Inc.
    Inventors: Ravi Thadhani, S. Ananth Karumanchi, Anders Hayden Berg, Ishir Bhan
  • Patent number: 9329190
    Abstract: Described herein are assays directed to determining the level of bioavailable or free vitamin D in a blood sample in a subject. The values determined for bioavailable or free vitamin D indicate whether the subject suffers from insufficient levels of vitamin D. Also described herein are methods of treatment for vitamin D insufficiency.
    Type: Grant
    Filed: January 6, 2012
    Date of Patent: May 3, 2016
    Assignees: The General Hospital Corporation, Beth Israel Deaconess Medical Center, Inc.
    Inventors: Ravi Thadhani, S. Ananth Karumanchi, Anders Hayden Berg, Ishir Bhan
  • Publication number: 20160077115
    Abstract: Described herein are assays directed to determining the level of bioavailable or free vitamin D in a blood sample in a subject. The values determined for bioavailable or free vitamin D indicate whether the subject suffers from insufficient levels of vitamin D. Also described herein are methods of treatment for vitamin D insufficiency.
    Type: Application
    Filed: May 2, 2014
    Publication date: March 17, 2016
    Applicant: The General Hospital Corporation
    Inventors: Ravi Thadhani, S. Ananth Karumanchi, Anders Hayden Berg, Ishir Bhan
  • Patent number: 9217748
    Abstract: Described herein are assays directed to determining the level of bioavailable or free vitamin D in a blood sample in a subject. The values determined for bioavailable or free vitamin D indicate whether the subject suffers from insufficient levels of vitamin D. Also described herein are methods of treatment for vitamin D insufficiency.
    Type: Grant
    Filed: January 6, 2012
    Date of Patent: December 22, 2015
    Assignees: The General Hospital Corporation, Beth Israel Deaconess Medical Center, Inc.
    Inventors: Ravi Thadhani, S. Ananth Karumanchi, Anders Hayden Berg, Ishir Bhan
  • Publication number: 20150247872
    Abstract: Described herein are assays directed to determining the level of bioavailable or free vitamin D in a blood sample in a subject. The values determined for bioavailable or free vitamin D indicate whether the subject suffers from insufficient levels of vitamin D Also described herein are methods of treatment for vitamin D insufficiency.
    Type: Application
    Filed: May 11, 2015
    Publication date: September 3, 2015
    Inventors: Ravi Thadhani, S. Ananth Karumanchi, Anders Hayden Berg, Ishir Bhan
  • Patent number: 9052308
    Abstract: Described herein are assays directed to determining the level of bioavailable or free vitamin D in a blood sample in a subject. The values determined for bioavailable or free vitamin D indicate whether the subject suffers from insufficient levels of vitamin D. Also described herein are methods of treatment for vitamin D insufficiency.
    Type: Grant
    Filed: June 14, 2013
    Date of Patent: June 9, 2015
    Assignees: The General Hospital Corporation, Beth Israel Deaconess Medical Center, Inc.
    Inventors: Ravi Thadhani, S. Ananth Karumanchi, Anders Hayden Berg, Ishir Bhan
  • Publication number: 20140113885
    Abstract: Described herein are assays directed to determining the level of bioavailable or free vitamin D in a blood sample in a subject. The values determined for bioavailable or free vitamin D indicate whether the subject suffers from insufficient levels of vitamin D. Also described herein are methods of treatment for vitamin D insufficiency.
    Type: Application
    Filed: January 6, 2012
    Publication date: April 24, 2014
    Inventors: Ravi Thadhani, S. Ananth Karumanchi, Anders Hayden Berg, Ishir Bhan
  • Publication number: 20130324505
    Abstract: Described herein are assays directed to determining the level of bioavailable or free vitamin D in a blood sample in a subject. The values determined for bioavailable or free vitamin D indicate whether the subject suffers from insufficient levels of vitamin D. Also described herein are methods of treatment for vitamin D insufficiency.
    Type: Application
    Filed: June 14, 2013
    Publication date: December 5, 2013
    Inventors: Ravi Thadhani, S. Ananth Karumanchi, Anders Hayden Berg, Ishir Bhan